New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment—which depletes the B cells that contribute to the MS attacks—are able to mount robust T-cell responses to the mRNA COVID-19 ...
Sep 15, 2021
0
176
Researchers from Fred Hutchinson Cancer Center in Seattle, Scripps Research in La Jolla, California, IAVI and other collaborating institutions have characterized robust T-cell responses in volunteers participating in the ...
May 24, 2023
0
55
Cancer patients who have compromised immune systems due to their disease or therapy remain at high risk for COVID-19 infection. It is why this population was one of the first to receive the COVID-19 vaccine. However, while ...
Mar 10, 2022
0
33
Using a monkey model of AIDS, scientists have identified a vaccine-generated immune-system response that correlates with protection against infection by the monkey version of HIV, called simian immunodeficiency virus (SIV). ...
May 5, 2011
0
0
Those widely available COVID-19 vaccinations keeping the majority of the population free from serious illness will not be enough to stop the spread of the virus and its variants, new University of Virginia collaborative research ...
Jul 19, 2022
0
250
When it comes to long-lasting protection against COVID-19, antibodies are our biggest allies, a new Yale University study shows.
Sep 3, 2021
0
219
Nearly 100 percent of cancer patients with solid tumors have antibodies effective against the delta variant after a third dose of COVID-19 vaccine, according to new results published as a correspondence in Cancer Cell this ...
Dec 23, 2021
0
59
Variants of the coronavirus have come to represent the ultimate danger: A curveball in our plans to bring an end to the pandemic that has ravaged our world and taken millions of lives. And here's another one—omicron—that ...
Dec 14, 2021
0
13
As concerns about the omicron variant mount, federal public health officials have strengthened their stance on booster shots for COVID-19 vaccines.
Dec 1, 2021
0
18
Antibodies that protect against H7N9 avian flu, which emerged in China in 2013 and sparked fears of a global pandemic, have been isolated in individuals who received seasonal flu vaccinations. These antibodies account for ...
Feb 17, 2015
0
54
